Proteins that protect movement and thinking in Alzheimer's

Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain

['FUNDING_R01'] · RUSH UNIVERSITY MEDICAL CENTER · NIH-11249626

This project looks for proteins in motor brain and nerve tissues that help older adults with Alzheimer's or related dementias keep moving and thinking better.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorRUSH UNIVERSITY MEDICAL CENTER (nih funded)
Locations1 site (CHICAGO, UNITED STATES)
Trial IDNIH-11249626 on ClinicalTrials.gov

What this research studies

Researchers will analyze key motor regions of the brain and related tissues using deep omics (large-scale protein and gene analyses) to find proteins linked to slower movement and cognitive decline despite Alzheimer’s pathology. They will compare samples from adults who have similar Alzheimer’s pathology but very different rates of motor loss to pinpoint resilience proteins. The team will then test whether the same proteins that support motor resilience also support thinking and memory. This work builds on prior omics discoveries in cognitive brain regions and is carried out at Rush University.

Who could benefit from this research

Good fit: Ideal candidates are older adults with Alzheimer's disease or related dementias, particularly those enrolled in memory or brain-donation cohorts or willing to provide samples.

Not a fit: People without Alzheimer’s-type brain pathology or whose mobility problems arise from non-neurological causes may not see direct benefit from these findings.

Why it matters

Potential benefit: If successful, it could identify targets for new tests or treatments to help people with Alzheimer's keep movement and thinking abilities longer.

How similar studies have performed: Previous deep-omics work has revealed candidate resilience proteins in cognitive brain regions, but applying these methods to motor tissues is newer and less-tested.

Where this research is happening

CHICAGO, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.